Search research articles
Contact Us
Filters
Showing results (151-160 of 175) with videos related to
Page
of 18
Sort By:
British Journal of Cancer
|
December 18, 2001
Influence of angiogenetic factors and matrix metalloproteinases upon tumour progression in non-small-cell lung cancer
Y Shou, T Hirano, Y Gong, et al.
The Journal of Experimental Medicine
|
March 1, 1996
Erythropoietin-independent erythrocyte production: signals through gp130 and c-kit dramatically promote erythropoiesis from human CD34+ cells
X Sui, K Tsuji, S Tajima, et al.
International Journal of Oncology
|
November 24, 1999
Detection of telomerase activity in exfoliated cancer cells obtained from bile
T Itoi, K Ohyashiki, N Yahata, et al.
British Journal of Cancer
|
January 1, 1997
Relationship between TA01 and TA02 polypeptides associated with lung adenocarcinoma and histocytological features
T Hirano, K Fujioka, B Franzèn, et al.
International Journal of Hematology
|
July 25, 2000
Massive pericardial and pleural effusion with anasarca following allogeneic bone marrow transplantation
T Ueda, A Manabe, A Kikuchi, et al.
The Journal of Experimental Medicine
|
October 1, 1996
Analysis of interleukin 6 receptor and gp130 expressions and proliferative capability of human CD34+ cells
S Tajima, K Tsuji, Y Ebihara, et al.
Blood
|
January 12, 2001
CD34 expression on long-term repopulating hematopoietic stem cells changes during developmental stages
S Matsuoka, Y Ebihara, M Xu, et al.
Blood
|
June 22, 2001
Generation of definitive hematopoietic stem cells from murine early yolk sac and paraaortic splanchnopleures by aorta-gonad-mesonephros region-derived stromal cells
S Matsuoka, K Tsuji, H Hisakawa, et al.
Japanese Journal of Cancer Research : Gann
|
October 26, 2000
Human tissue distribution of TA02, which is homologous with a new type of aspartic proteinase, napsin A
T Hirano, G Auer, M Maeda, et al.
The Journal of Clinical Investigation
|
April 5, 2000
Expansion of human NOD/SCID-repopulating cells by stem cell factor, Flk2/Flt3 ligand, thrombopoietin, IL-6, and soluble IL-6 receptor
T Ueda, K Tsuji, H Yoshino, et al.
Page
of 18
Search research articles
Search
Showing results (151-160 of 175) with videos related to
Sort By:
Page
of 18
British Journal of Cancer
|
December 18, 2001
Influence of angiogenetic factors and matrix metalloproteinases upon tumour progression in non-small-cell lung cancer
Y Shou, T Hirano, Y Gong, et al.
The Journal of Experimental Medicine
|
March 1, 1996
Erythropoietin-independent erythrocyte production: signals through gp130 and c-kit dramatically promote erythropoiesis from human CD34+ cells
X Sui, K Tsuji, S Tajima, et al.
International Journal of Oncology
|
November 24, 1999
Detection of telomerase activity in exfoliated cancer cells obtained from bile
T Itoi, K Ohyashiki, N Yahata, et al.
British Journal of Cancer
|
January 1, 1997
Relationship between TA01 and TA02 polypeptides associated with lung adenocarcinoma and histocytological features
T Hirano, K Fujioka, B Franzèn, et al.
International Journal of Hematology
|
July 25, 2000
Massive pericardial and pleural effusion with anasarca following allogeneic bone marrow transplantation
T Ueda, A Manabe, A Kikuchi, et al.
The Journal of Experimental Medicine
|
October 1, 1996
Analysis of interleukin 6 receptor and gp130 expressions and proliferative capability of human CD34+ cells
S Tajima, K Tsuji, Y Ebihara, et al.
Blood
|
January 12, 2001
CD34 expression on long-term repopulating hematopoietic stem cells changes during developmental stages
S Matsuoka, Y Ebihara, M Xu, et al.
Blood
|
June 22, 2001
Generation of definitive hematopoietic stem cells from murine early yolk sac and paraaortic splanchnopleures by aorta-gonad-mesonephros region-derived stromal cells
S Matsuoka, K Tsuji, H Hisakawa, et al.
Japanese Journal of Cancer Research : Gann
|
October 26, 2000
Human tissue distribution of TA02, which is homologous with a new type of aspartic proteinase, napsin A
T Hirano, G Auer, M Maeda, et al.
The Journal of Clinical Investigation
|
April 5, 2000
Expansion of human NOD/SCID-repopulating cells by stem cell factor, Flk2/Flt3 ligand, thrombopoietin, IL-6, and soluble IL-6 receptor
T Ueda, K Tsuji, H Yoshino, et al.
Page
of 18